MANNING MARTHA E
Insider CIK 1227894 · ACHN General Counsel · MRNS VP, Gen. Counsel & Corp. Sec.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,900 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 74,468 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 98,250 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 75,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 49,125 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 57,500 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-11 | 2025-02-11 | 48,077 | $0.55 | $26.4K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 12,186 | $0.55 | $6.7K | 48,077 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-08-05 | 2024-08-07 | 3,621 | $1.13 | $4.1K | 60,263 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 49,125 | — | $0 | 49,125 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 10,918 | — | $0 | 63,884 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-02-20 | 2024-02-22 | 1,894 | $9.57 | $18.1K | 52,966 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 98,250 | — | $0 | 98,250 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 21,835 | — | $0 | 54,860 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-08 | 2023-08-08 | 11 | $8.93 | $98 | 33,025 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-08 | 2,169 | $9.54 | $20.7K | 33,036 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 74,468 | — | $0 | 74,468 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 16,548 | — | $0 | 35,205 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2022-05-24 | 2022-05-26 | 5,790 | — | $0 | 18,657 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2022-02-04 | 2022-02-07 | 57,900 | — | $0 | 57,900 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2022-02-04 | 2022-02-07 | 12,867 | — | $0 | 12,867 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2021-01-15 | 2021-01-19 | 57,500 | — | $0 | 57,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2020-06-15 | 2020-06-17 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-29 | 2020-01-29 | 110,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-29 | 2020-01-29 | 135,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 150,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 215,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer | 2020-01-28 | 2020-01-29 | 2,500 | $6.30 | $15.8K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 215,000 | — | $0 | 215,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-17 | 2017-01-19 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2016-12-02 | 2016-12-05 | 2,500 | $4.09 | $10.2K | 2,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-02-01 | 2016-02-03 | 110,000 | — | $0 | 110,000 | SEC↗ |